美券商Evercore ISI料標普500指數明年底見7,750點 較現水平高兩成
《彭博》報道,美國券商Evercore ISI首席股票及量化策略師Julian Emanuel發表報告,預期標普500指數明年底升至7,750點,較現水平高兩成,認為人工智能科技革命推升股票、估值及社會至新高度。該預測為各券商中最為樂觀。
該行亦上調對標普500指數今年目標至6,250點,低於上周收市的6,460點及市場預期平均的6,370點。該行亦承認明年或出現廣泛可能性,在激發「動物本能」的最牛情況下標普500指數見9,000點,在通脹高企及經濟增長呆滯的最熊情況下標普500指數可跌至5,000點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.